Evaluation of cannabidiol’s inhibitory effect on alpha-glucosidase and its stability in simulated gastric and intestinal fluids

OBJECTIVE: Cannabidiol (CBD) has been reported to have anti-diabetic effects in pre-clinical and clinical studies but its inhibitory effects on α-glucosidase, a carbohydrate hydrolyzing enzyme, remain unknown. Herein, we evaluated CBD’s inhibitory effects on α-glucosidase using in vitro assays and c...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Hang, Li, Huifang, Liu, Chang, Seeram, Navindra P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Brief Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8223390/
https://www.ncbi.nlm.nih.gov/pubmed/34162444
http://dx.doi.org/10.1186/s42238-021-00077-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8223390/
https://www.ncbi.nlm.nih.gov/pubmed/34162444
http://dx.doi.org/10.1186/s42238-021-00077-x

Ejemplares similares